Serological survey of viral hepatitis A, B, and C at Thai central region and Bangkok: A population base studyRATANASUWAN, Winai; SONJI, Areeua; TIENGRIM, Surapee et al.Southeast Asian journal of tropical medicine and public health. 2004, Vol 35, Num 2, pp 416-420, issn 0125-1562, 5 p.Article

Overcoming Resistance to Existing Therapies in HIV-Infected Patients : The Role of New Antiretroviral DrugsPERNO, Carlo-Federico; MOYLE, Graeme; TSOUKAS, Chris et al.Journal of medical virology. 2008, Vol 80, Num 4, pp 565-576, issn 0146-6615, 12 p.Article

Plasma levels of soluble CD14 and tumor necrosis factor-α type II receptor correlate with cognitive dysfunction during human immunodeficiency virus type 1 infectionRYAN, Lisa A; JIALIN ZHENG; BRESTER, Michelle et al.The Journal of infectious diseases. 2001, Vol 184, Num 6, pp 699-706, issn 0022-1899Article

Three-year durability of dual-nucleoside versus triple-nucleoside therapy in a thai population with HIV infectionUNGSEDHAPAND, Chaiwat; SRASUEBKUL, Preeyaporn; EMERY, Sean et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 2, pp 693-701, issn 1525-4135, 9 p.Article

Sustained Antiretroviral Effect of Raltegravir After 96 Weeks of Combination Therapy in Treatment-Naive Patients With HIV-1 InfectionMARKOWITZ, Martin; NGUYEN, Bach-Yen; CAMPBELL, Havilland et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 3, pp 350-356, issn 1525-4135, 7 p.Article

Sustained Efficacy and Safety of Raltegravir After 5 Years of Combination Antiretroviral Therapy as Initial Treatment of HIV-1 Infection: Final Results of a Randomized, Controlled, Phase II Study (Protocol 004)GOTUZZO, Eduardo; MARKOWITZ, Martin; TEPPLER, Hedy et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 1, pp 73-77, issn 1525-4135, 5 p.Article